# Ambalal Sarabhai Enterprises Ltd (AMBALALSA)
> Exchange: NSE | Sector: Pharma | ISIN: INE432A01017

## Price
Current Price: ₹32.75
Day Change: -0.27%
52W High: ₹36.15
52W Low: ₹30.3
Market Cap: ₹0 Cr

## Valuation
P/E: 24
P/B: 1.77
EPS: ₹1.36
Book Value: ₹18.44
Dividend Yield: 0%

## Returns
1Y Return: -14.8%

## Profitability
ROE: 0%
ROCE: 7.71%
Debt/Equity: 0.32
Revenue Growth: 13.1%
Profit Growth: 37.9%
EBITDA Margin: 10.9%
Operating Margin: 10.95%

## About
Ambalal Sarabhai Enterprises Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Ambalal Sarabhai Enterprises Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Quarterly Report: Board Meeting Intimation for Approval Of Audited Financial Results As On 31.03.2026
- Announcement: Intimation Regarding Change In Branch Address Of Registrar & Share Transfer Agent (MCS Share Transfer Agent Limited)
- BSE Filing: Intimation Regarding Change In Branch Address Of Registrar & Share Transfer Agent (MCS Share Transfer Agent Limited)

## Access
Current tier: anonymous
More history: Register free to see 13 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:00.503Z
Price History Updated: 2026-05-17T21:24:03.192Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:24:03.192Z
Quant Updated: 2026-05-17T21:24:03.192Z
Sentiment Updated: 2026-05-17T21:24:03.192Z
Financials Status: current
Financials Updated: 2026-05-22T07:38:54.448Z
Financials Last Attempt: 2026-05-22T07:38:54.448Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹195.31 Cr
Operating Profit: ₹9.24 Cr (OPM 4.73%)
Net Profit: ₹4.93 Cr
Tax: ₹-0.1 Cr

## Annual P&L History
FY25: Rev ₹195.31Cr | PAT ₹4.93Cr | OPM 4.73%
FY24: Rev ₹172.94Cr | PAT ₹5.68Cr | OPM 3.03%
FY23: Rev ₹169.64Cr | PAT ₹11.45Cr | OPM 4.16%

## Balance Sheet (FY25)
Total Assets: ₹270.04 Cr
Total Liabilities: ₹130.07 Cr
Borrowings: ₹50.89 Cr
Cash: ₹4.89 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Kartikeya Vikram Sarabhai M.A., Executive Chairman & Whole Time Director
- Mohal Kartikeya Sarabhai, MD & Director
- Jinal Jaykumar Shah, Chief Financial Officer
- Disha Mahesh Punjani, Company Secretary & Compliance Officer
- Chaula M. Shastri, Whole-Time Director

---
Source: rupiya.io/stocks/ambalalsa
Disclaimer: For research and education only. Not investment advice.